Table 3 summarizes the available studies on aPL and native AVF thrombosis. A systematic review and meta-analysis confirmed the association between aPL (lupus anticoagulant and IgG aCL) and AVF thrombosis [15]. Non-criteria antibodies that are not included in the 2023 ACR/EULAR classification criteria for APS have been associated with AVF thrombosis such as IgA aβ2GPI [21,22,42]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.